Join Dr Paul Mattick, Head of sales and investor relations at Mercia, and Chris Kilroy of the Mercia EIS investment team, who answer questions surrounding the impact of COVID-19 on Mercia’s EIS Funds, how its impacted the valuation and how Mercia are supporting their portfolio companies in the next period.
